List of insiders holdings for Black Diamond Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
BIOTECH GROWTH N V BB BIOTECH AG 10% Owner | 2024-02-13 06:05:56 | 8,517,839 0 | 8,517,839 | Form 13G |
Versant Venture Capital VI L.P. Versant Voyageurs I L.P. Versant Voyageurs I Parallel L.P. Versant Vantage I L.P. 10% Owner | 2024-08-30 16:16:52 | 3,726,341 2,480,623 | 6,206,964 | Form 4 |
New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 2024-05-13 19:09:49 | 4,546,947 0 | 4,546,947 | Form 13D |
Behbahani Ali Director | 2024-12-16 17:09:54 | 63,334 4,448,757 | 4,512,091 | Form 4 |
RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director | 2024-05-09 20:48:15 | 2,788,028 0 | 2,788,028 | Form 13D |
BASKETT FOREST 10% Owner | 2020-01-29 20:10:17 | 0 2,648,757 | 2,648,757 | Form 3 |
Walker Paul Edward 10% Owner | 2020-01-29 20:15:53 | 0 2,648,757 | 2,648,757 | Form 3 |
Sonsini Peter W. 10% Owner | 2020-01-29 20:15:25 | 0 2,648,757 | 2,648,757 | Form 3 |
MOTT DAVID M 10% Owner | 2020-01-29 20:14:13 | 0 2,648,757 | 2,648,757 | Form 3 |
Chang Carmen 10% Owner | 2020-01-29 20:11:35 | 0 2,648,757 | 2,648,757 | Form 3 |
Florence Anthony A. Jr. 10% Owner | 2020-01-29 20:12:09 | 0 2,648,757 | 2,648,757 | Form 3 |
Makhzoumi Mohamad 10% Owner | 2020-01-29 20:12:49 | 0 2,648,757 | 2,648,757 | Form 3 |
MAKOWER JOSHUA 10% Owner | 2020-01-29 20:13:38 | 0 2,648,757 | 2,648,757 | Form 3 |
SANDELL SCOTT D 10% Owner | 2020-01-29 20:14:52 | 0 2,648,757 | 2,648,757 | Form 3 |
Epstein David M. SEE REMARKS | 2023-06-28 16:02:20 | 671,423 265,146 | 936,569 | Form 4 |
Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Possible Member of 10% Group 10% Owner | 2020-02-03 13:28:40 | 778,789 0 | 778,789 | Form 13G |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 2020-02-05 18:06:04 | 568,185 0 | 568,185 | Form 4 |
Velleca Mark A. PRESIDENT & CEO | 2024-02-15 17:35:28 | 537,000 0 | 537,000 | Form 4 |
Yurasov Sergey CHIEF MEDICAL OFFICER | 2024-02-15 17:37:35 | 225,000 0 | 225,000 | Form 4 |
Buck Elizabeth CHIEF SCIENTIFIC OFFICER | 2024-02-15 17:36:27 | 200,000 0 | 200,000 | Form 4 |
Hatzis-Schoch Brent SEE REMARKS | 2024-02-15 17:38:54 | 200,000 0 | 200,000 | Form 4 |
Ni Fang SEE REMARKS | 2024-02-15 17:45:43 | 200,000 0 | 200,000 | Form 4 |
Roberts Christopher D. Chief Scientific Officer | 2021-05-05 16:31:37 | 166,809 0 | 166,809 | Form 4 |
Jones Erika SEE REMARKS | 2024-02-15 17:34:08 | 100,000 0 | 100,000 | Form 4 |
Leggett Thomas Chief Financial Officer | 2021-02-19 18:47:29 | 75,000 0 | 75,000 | Form 4 |
HUMPHREY RACHEL Chief Medical Officer | 2021-02-19 18:55:27 | 60,000 0 | 60,000 | Form 4 |
INGRAM ROBERT ALEXANDER FORMER DIRECTOR Director | 2022-12-19 21:14:26 | 42,854 0 | 42,854 | Form 4 |
DIXON WENDY L Director | 2024-04-03 20:49:49 | 38,054 0 | 38,054 | Form 4 |
Dhingra Kapil Director | 2024-06-06 17:50:48 | 30,550 0 | 30,550 | Form 4 |
Menzel Garry E Director | 2024-06-06 17:54:34 | 30,550 0 | 30,550 | Form 4 |
Kulkarni Samarth Director | 2024-06-06 17:55:15 | 30,550 0 | 30,550 | Form 4 |
Mayweg Alexander Director | 2023-05-17 21:11:09 | 16,500 0 | 16,500 | Form 4 |
Bolzon Bradley J PhD Director 10% Owner | 2021-06-22 18:12:19 | 15,000 0 | 15,000 | Form 4 |
Raman Prakash Director | 2024-12-16 16:34:40 | 10,145 0 | 10,145 | Form 4 |
Campbell Shannon Director | 2024-12-16 16:34:15 | 8,865 0 | 8,865 | Form 4 |